CINA-PE

Avicenna.AI
CINA-PE is a radiological computer aided triage and notification software indicated for use in the analysis of chest and thoraco-abdominal CT angiographies. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of chest CT angiographies for pulmonary embolism (PE). CINA-PE uses an artificial intelligence algorithm to analyze images and highlight cases with detected PE on a standalone web application in parallel to the ongoing standard of care image interpretation.
Information source: Vendor
Last updated: Jan. 18, 2024

General Information

General
Product name CINA-PE
Company Avicenna.AI
Subspeciality Chest
Modality CT
Disease targeted Pulmonary embolism
Key-features Pulmonary embolism detection, pulmonary embolism triage
Suggested use Before: adapting worklist order

Technical Specifications

Data characteristics
Population Adults suspected of pulmonary embolism
Input Chest and thoraco-abdominal CT angiographies (CTA)
Input format DICOM
Output bounding box annotation, notification
Output format DICOM SC, GSPS
Technology
Integration Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds

Regulatory

Certification
CE
Certified, Class I , MDD
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) CINA CHEST is a radiological computer aided triage and notification software indicated for use in the analysis of Chest and Thoraco-abdominal CT angiography. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of (1) Chest CT angiography for Pulmonary Embolism (PE) and (2) Chest or Thoraco-abdominal CT angiography for Aortic Dissection (AD). CINA CHEST uses an artificial intelligence algorithm to analyze images and highlight cases with detected PE and AD on a standalone Web application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE or AD findings. Notifications include compressed preview images that are meant for informational purposes only, and are not intended for diagnostic use beyond notification. The device does not alter the original medical image, and it is not intended to be used as a diagnostic device. The results of CINA CHEST are intended to be used in conjunction with other patient information and based on professional judgment to assist with triage/prioritization of medical images. Notified clinicians are ultimately responsible for reviewing full images per the standard of care.

Market

Market presence
On market since 12-2020
Distribution channels Viz.ai Platform, CARPL.ai, Eureka Clinical AI
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance

  • A deep learning-based algorithm improves radiology residents’ diagnoses of acute pulmonary embolism on CT pulmonary angiograms (read)

  • Deep Learning-Based Algorithm for Automatic Detection of Pulmonary Embolism in Chest CT Angiograms (read)

Non-peer reviewed papers on performance
Other relevant papers